Vernal Keratoconjunctivitis Clinical Trial
Official title:
A Phase 1b, Open-Label, Multiple Dose, Proof-of-Concept Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of AK002 in Patients With Atopic Keratoconjunctivitis, Vernal Keratoconjunctivitis, and Perennial Allergic Conjunctivitis
This is a Phase 1b, open-label, study to assess the effects of AK002, given as monthly intravenous infusion for 6 doses at up to 3 mg/kg.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05076084 -
Evaluation of the Efficacy and Safety of Tacrolimus Drops in Children With Vernal Keratoconjunctivitis
|
||
| Recruiting |
NCT02057822 -
Cytokine Assay in Tears of Healthy Children and With Vernal Keratoconjunctivitis: Case Control Study and Monitoring of Cases at 6 Months
|
N/A | |
| Completed |
NCT03464435 -
A Novel Combined Therapy for Refractory Vernal Keratoconjunctivitis
|
Phase 4 | |
| Completed |
NCT00445120 -
Lactobacillus Rhamnosus GG Oral Treatment Efficacy on Vernal Keratoconjunctivitis Treatment
|
Phase 2/Phase 3 | |
| Recruiting |
NCT03557203 -
Dermatologic Tacrolimus Ointment on Eyelids in the Treatment of Refractory Vernal Keratoconjunctivitis and Atopic Keratoconjunctivitis
|
||
| Completed |
NCT01211327 -
Topical Cyclosporine for Vernal Keratoconjunctivitis (VKC) in Rwanda
|
Phase 4 | |
| Completed |
NCT05353101 -
Cyclosporine 0.05% Eye Drops for Vernal Keratoconjunctivitis Trial
|
Phase 1 | |
| Not yet recruiting |
NCT04705584 -
Topical Immuonosuppressant Drugs in Spring Catarrh
|
N/A | |
| Completed |
NCT00426023 -
Cyclosporin A Eye Drop Treatment in Vernal Keratoconjunctivitis
|
Phase 3 | |
| Completed |
NCT01751126 -
Double-Masked Trial of NOVA22007 (1mg/mL Ciclosporin/Cyclosporine) Versus Vehicle in Pediatric Patients With Active Severe Vernal Keratoconjunctivitis
|
Phase 3 | |
| Recruiting |
NCT02456025 -
Topical Tacrolimus in Vernal Keratoconjunctivitis
|
Phase 4 |